News & partners

Dianosic is a biotech focused on the development of novel solutions integrated drug and
delivery system for the localized treatment of patients with chronic rhinitis and chronic rhinosinusitis.

Latest news

Avr 19, 2021

Snitem – Dianosic reçoit le prix “coup de coeur” du public

See more
Our investors

We built a solid network of partners to support company funding and growth.

Fondation Force
Bpi France
Banque Populaire Rives de Paris
Caisse d’épargne Grand Est
Wiseed